Effectiveness of the Virtual Reality System Toyra on Upper Limb Function in People with Tetraplegia: A Pilot Randomized Clinical Trial

Table 3

Pre- and follow-up assessment results of clinical and functional variables.

Variables		Preassessment		Follow-up assessment		Follow-up basal difference
		Mean	SD	Mean	SD	Mean	IC 95%
SCIM III self-care	GC	3,87	4,64	7,36	7,08	3,49	(−5,525 a −0,839)	0,944	0
	IG	3,25	2,30	6,64	7,08	3,39	(−4,893 a −1,652)
		0,64		0,76
FIM	GC	64,20	14,57	77,00	25,15	12,80	(−21,066 a −1,843)	0,799	0,003
	IG	60,69	6,78	69,91	12,01	9,22	(−16,866 a −3,316)
		0,39		0,41
BI	GC	18,33	16,33	40,00	26,17	21,67	(−30,997 a −7,185)	0,3	0,054
	IG	18,13	12,76	30,45	10,11	12,32	(−20,131 a −4,415)
		0,97		0,27
MB	GC	13,07	5,71	16,50	5,53	3,43	(−3,264 a −0,736)	0,043	0,22
	IG	13,75	5,22	13,36	5,53	-0,39	(−1,465 a 0,374)
		0,73		0,18
MI	GC	70,53	18,44	86,50	14,83	15,97	(−26,054 a 1,054)	0,884	0,001
	IG	68,13	12,88	81,45	12,05	13,32	(−21,535 a −5,374)
		0,68		0,42

.